Semax 10mg Research Peptide Canada

Semax (10 mg) is a research‑grade synthetic heptapeptide derived from the ACTH(4‑10) fragment, widely referenced in Canadian laboratory environments for studies involving neuromodulation, cognitive‑pathway signalling, stress‑response modelling, and peptide–receptor interaction dynamics.

Engineered for in‑vitro and preclinical research, Semax is valued for its stability, mechanistic specificity, and broad relevance to neurochemical signalling pathways, making it a commonly referenced peptide in Canadian laboratory studies of central‑pathway regulation, transcriptional activity, and peptide‑mediated cellular communication.

Semax is a synthetic ACTH‑derived heptapeptide designed for controlled research use in studies involving:

• Neuromodulatory signalling pathways
• Peptide–receptor interaction models
• Stress‑response and adaptation mechanisms
• Cognitive‑pathway transcriptional activity
• Peptide stability and degradation‑resistance profiling
• Multi‑pathway neurochemical investigations

Its compact structure and predictable behaviour make Semax a widely used model compound for neurobiological, biochemical, and peptide‑mechanism research across Canada.

🔷 Neuromodulatory Signalling

• Referenced in studies involving ACTH‑fragment signalling
• Supports mapping of neurochemical pathway activation
• Used in models examining peptide‑mediated receptor interactions

🔶 Stress‑Response & Adaptation Pathways

• Applied in research involving oxidative‑stress markers
• Supports investigations into cellular resilience and adaptive signalling
• Used in multi‑pathway stress‑response modelling

🔵 Transcriptional & Peptide‑Interaction Dynamics

• Examined in studies involving transcriptional‑cascade activity
• Supports peptide–protein interaction modelling
• Used in comparative studies vs. other ACTH‑derived fragments

Molecular Composition

• Type: Synthetic heptapeptide
• Form: Lyophilized powder (10 mg fill)
• Identity: Verified via MS and HPLC/UPLC
• Origin: Derived from ACTH(4‑10) sequence

Functional Domains

• Neuromodulation domain: ACTH‑fragment signalling
• Stress‑response domain: Oxidative‑marker and adaptation models
• Interaction domain: Peptide–protein binding and structural modelling

🎯 Pathway Targets

• Neurochemical signalling pathways
• Stress‑response and adaptation markers
• Transcriptional‑activation cascades
• Peptide–receptor interaction networks

Semax is referenced in research involving:

• Neuromodulation and cognitive‑pathway modelling
• Stress‑response and oxidative‑marker studies
• Peptide‑receptor interaction assays
• Transcriptional‑cascade and signalling‑pathway mapping
• Comparative ACTH‑fragment analysis
• Multi‑pathway neurochemical investigations

Its clean mechanistic profile makes it suitable for controlled, pathway-specific research environments across Canada.

BlueNex Labs supplies Semax to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and Canada‑wide, offering:

• lot-documented peptide materials
• Consistent batch quality and traceability
• Audit‑safe RUO labelling
• Ships inside Canada by Canada Post Xpresspost with tracking
• Research‑focused support for neurochemical and signalling‑pathway studies

This ensures Canadian researchers have reliable access to ACTH-derived research peptides for advanced mechanistic modelling.

Each batch includes:

• MS identity confirmation
• HPLC / UPLC purity results
• Lot and batch traceability

Reports, when published, are linked from the certificates library.

Research use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.

• Store lyophilized material at −20 °C, protected from light and moisture
• Avoid repeated freeze–thaw cycles; aliquot according to your laboratory SOP